Results of this study show that even though raw phytosterols and their microencapsulated form (LIPOPHYTOL™) reduce the cholesterol in a similar extent, LIPOPHYTOL™ is more effective decreasing the hypertriglyceridemia and against atherogenesis under a high-fat diet, demonstrating microencapsulation technology might enhance the activity of phytosterols.
Despite with the current data, a mechanism cannot be suggested to explain these observations. Extrapolation of these results to humans might suggest that LIPOPHYTOL™ is a more suitable additive to be consumed by the general population.
Download this free white paper to find out more.
Download to find out more.